Company
Cellbyte
The collaborative AI workspace for Pricing & Market Access teams which seamlessly integrates into your everyday work.
Also known as Cellbyte GmbH
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Headquarters
- Munich, Bayern, Germany
- Founded
- 2024
- Customers
- pharmaceutical companies
- Legal name
- Cellbyte GmbH
Record updated 20 September 2026
About
Cellbyte has developed an AI-native platform for teams involved in drug launches, which allows them to effortlessly analyse millions of data points in real time across clinical, pricing, HTA and regulatory data, as well as internal company sources.
Funding snapshot
- Total raised
- $2.8MSum of rounds, as of 2026-09-20Source (opens in a new tab)
- Latest round
- Seed, $2.8M2025-11-18
Funding rounds
- Seed
- $2.8M2025-11-18, Company stated
Products
- Web
- Cellbyte